Cyclosporine-Associated Leukoencephalopathy in a Case of Sympathetic Ophthalmitis
Purpose: Cyclosporine (CsA) is currently widely used as a primary immunosuppressive agent in ocular disease, particularly in severe uveitis. Posterior reversible encephalopathy syndrome (PRES) is a significant complication of CsA therapy. However, there are no reports of the occurrence of PRES in re...
Main Authors: | Mizuki Tagami, Atsushi Azumi |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2016-01-01
|
Series: | Case Reports in Ophthalmology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/443826 |
Similar Items
-
Cyclosporin-A induced Posterior Reversible Encephalopathy Syndrome
by: Saeed Bassam, et al.
Published: (2008-01-01) -
Posterior Reversible Leukoencephalopathy Secondary to Gemcitabine
by: Aslan Tekataş, et al.
Published: (2014-03-01) -
Posterior Reversible Leukoencephalopathy Syndrome Associated with Pazopanib
by: Robert Foerster, et al.
Published: (2013-04-01) -
Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy
by: Jordi Gandini, et al.
Published: (2020-01-01) -
Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
by: White DE, et al.
Published: (2019-11-01)